Monte Rosa Therapeutics
Medicine and Health/Human Health and Social Work
Boston, GA, United States
Description
Experteer Insights
Experteer Briefing
Company Trajectory
Monte Rosa Therapeutics, founded in 2018, is headquartered in Boston, Massachusetts, United States. The company was established as a biotechnology firm focused on developing molecular glue degraders to target disease-causing proteins previously considered undruggable. Since its founding, Monte Rosa has progressed from early scientific innovation to building an advanced drug discovery engine, positioning itself as a leader in the molecular glue degrader field. The organization is not considered a start-up and continues to expand its research capabilities and therapeutic pipeline as it moves toward commercial readiness.
Financial Setup
Monte Rosa Therapeutics is a publicly traded company employing approximately 140 people. The company operates under a business-to-business (B2B) model, specializing in the development of molecular glue degrader medicines for oncology, autoimmune, and inflammatory diseases. The firm’s historical financial structure reflects a transition through phases of innovation and scaling, consistent with its position in the biotechnology sector. Monte Rosa’s ongoing financial strategy supports robust research and clinical development while focusing on long-term growth and shareholder value.
Development & Outlook
Monte Rosa Therapeutics specializes in the development of molecular glue degrader medicines targeting undruggable or inadequately drugged proteins. Its research pipeline features MRT-2359, aimed at MYC-driven tumors, and MRT-6160, targeting immune-mediated conditions, both leveraging the proprietary QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine. The company demonstrates dedication to corporate social responsibility by upholding ethical business practices, environmental sustainability, and engaging with the community. Monte Rosa actively supports patient advocacy groups and improves access to healthcare, reinforcing its commitment to innovation and societal impact as it advances novel therapies for challenging diseases.
Vacancies
Senior Scientist, Medicinal Chemistry -Lead Generation
Monte Rosa Therapeutics
Boston, MA - USA
Senior Scientist, Medicinal Chemistry -Lead Generation
Monte Rosa Therapeutics
Boston, MA - USA
Senior Manager, Accounting– Clinical Accruals
Monte Rosa Therapeutics
Boston, MA - USA
Senior Scientist, BioMarker & Translational Research
Monte Rosa Therapeutics
Boston, MA - USA
Co-op Research Associate in Software Development and Bioinformatics
Monte Rosa Therapeutics
Boston, MA - USA